Sweat chloride and lung function responses to elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis with two versus one responsive CFTR variants: an analysis of two real-world observational studies.
Burgel PR, Da Silva J, Girodon E, Durieu I, Reynaud-Gaubert M, Murris-Espin M, Chiron R, Grenet D, Ramel S, Mely L, Hamidfar R, Douvry B, Houdouin V, Audousset C, Macey J, Mittaine M, Weiss L, Cosson L, Danner-Boucher I, Reix P, Baravalle M, Burnet E, Sermet-Gaudelus I, Martin C, Paillasseur JL; French Cystic Fibrosis Reference Network study group.
Burgel PR, et al.
Lancet Respir Med. 2025 Nov;13(11):978-989. doi: 10.1016/S2213-2600(25)00190-0. Epub 2025 Sep 3.
Lancet Respir Med. 2025.
PMID: 40914184